Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: LGC, U of Southampton KASP Genotyping Assay

Premium

LGC, in collaboration with the University of Southampton, has developed a panel of 24 scientifically-validated KASP genotyping assays that enables identification of human samples based on a genotyping profile, the partners said this week.

The exome sample tracking panel allows sample identification in any research laboratory with basic PCR capacity and is a powerful tool for protecting sample provenance and ensuring integrity of data, the partners said.

Original samples are genotyped using KASP chemistry, resulting in a genotype profile that acts as an internal barcode for each sample. At the end of the project workflow, using next-generation sequencing data, samples can be referenced to their original profile to verify sample integrity.

"The product allows easy and robust identification of human samples at any stage in a genomics workflow and offers our customers a convenient method to prevent sample switches based on our robust and universally applicable KASP genotyping chemistry," Joris Parmentier, product manager for KASP assays and reagents at LGC, said in a statement.

The exome sample tracking panel has been validated on various populations, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.